Note: Ingredients listed on restricted chemical lists
EC/CAS
200-001-8/50-00-0
Name of the chemical
Formaldehyde
Concentration
35-40
EC/CAS
200-659-6/67-56-1
Name of the chemical
Methanol
Concentration
11-14
General Information
Version
1.4
Revision date
2023-09-12
Product name
Formaldehyde solution
Product name
Formaldehyde solution
Identification on the label/Trade name
Formaldehyde, solution 35-40% stabilized with methanol
Product Synonyms
methanol
CAS No.
50-00-0
1.2.1 Relevant identified uses
Laboratory use
Emergency telephone
+34 937 077 970, 0344 892 0111, +34 91 5620420
Icons in SDS
Company Information
company name
labbox labware s.l
e-mail address of the competent person responsible for the Safety Data Sheet
info@labbox.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H301+H311+H331, H311, H314, H317, H331, H335, H341, H350
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS06 GHS08
Signal word
Danger
Hazard statements
H301+H311+H331 - Toxic if swallowed, in contact with skin or if inhaled. H314 - Causes severe skin burns and eye damage. H317 - May cause an allergic skin reaction. H335 - May cause respiratory irritation. H341 - Suspected of causing genetic defects. H350 - May cause cancer.
Precautionary statements
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P260 - Do not breathe dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P271 - Use only outdoors or in a well-ventilated area.
PBT Substances
not relevant – no registration required Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605